MPP+-induced cytotoxicity in neuroblastoma cells: Antagonism and reversal by guanosine

作者: Kathleen M. Pettifer , Shucui Jiang , Christian Bau , Patrizia Ballerini , Iolanda D’Alimonte

DOI: 10.1007/S11302-007-9073-Z

关键词:

摘要: Guanosine exerts neuroprotective effects in the central nervous system. Apoptosis, a morphological form of programmed cell death, is implicated pathophysiology Parkinson’s disease (PD). MPP+, dopaminergic neurotoxin, produces vivo and vitro cellular changes characteristic PD, such as cytotoxicity, resulting apoptosis. Undifferentiated human SH-SY5Y neuroblastoma cells had been used an model disease. We investigated if extracellular guanosine affected MPP+-induced cytotoxicity examined molecular mechanisms mediating its effects. Exposure to MPP+ (10 μM–5 mM for 24–72 h) induced DNA fragmentation time-dependent manner (p < 0.05). Administration (100 μM) before, concomitantly with or, importantly, after addition abolished fragmentation. Addition (500 μM) increased caspase-3 activity over 72 h (p < 0.05), this was by pre- or co-treatment guanosine. pertussis toxin prior eliminated anti-apoptotic effect guanosine, indicating that dependent on Gi protein-coupled receptor, most likely putative receptor. The protection also selective inhibitor enzyme PI-3-K/Akt/PKB (LY294002), confirming pathway plays decisive role Neither nor any significant α-synuclein expression. Thus, antagonizes reverses via activation survival pathway, PI-3-K/Akt/PKB. Our results suggest may be effective pharmacological intervention PD.

参考文章(79)
Wakako Maruyama, Yukihiro Akao, Maria Chrisina Carrillo, Ken-ichi Kitani, Moussa B.H Youdium, Makoto Naoi, Neuroprotection by propargylamines in Parkinson's disease : suppression of apoptosis and induction of prosurvival genes Neurotoxicology and Teratology. ,vol. 24, pp. 675- 682 ,(2002) , 10.1016/S0892-0362(02)00221-0
Ugo Traversa, Giulia Bombi, Emidio Camaioni, Antonio Macchiarulo, Gabriele Costantino, Clara Palmieri, Francesco Caciagli, Roberto Pellicciari, Rat brain guanosine binding site Bioorganic & Medicinal Chemistry. ,vol. 11, pp. 5417- 5425 ,(2003) , 10.1016/J.BMC.2003.09.043
Fiona Thomson, Parkinson's Disease Neuron. ,vol. 39, pp. 889- 909 ,(2003) , 10.1016/S0896-6273(03)00568-3
Maria Grazia Spillantini, Marie Luise Schmidt, Virginia M.-Y. Lee, John Q. Trojanowski, Ross Jakes, Michel Goedert, α-Synuclein in Lewy bodies Nature. ,vol. 388, pp. 839- 840 ,(1997) , 10.1038/42166
Michal Hetman, Agata Gozdz, Role of extracellular signal regulated kinases 1 and 2 in neuronal survival FEBS Journal. ,vol. 271, pp. 2050- 2055 ,(2004) , 10.1111/J.1432-1033.2004.04133.X
Andreas Hartmann, Patrick P. Michel, Jean-Denis Troadec, Annick Mouatt-Prigent, Baptiste A. Faucheux, Merle Ruberg, Yves Agid, Etienne C. Hirsch, Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease? Journal of Neurochemistry. ,vol. 76, pp. 1785- 1793 ,(2001) , 10.1046/J.1471-4159.2001.00160.X
Graeme Milligan, Evi Kostenis, Heterotrimeric G-proteins: a short history British Journal of Pharmacology. ,vol. 147, ,(2006) , 10.1038/SJ.BJP.0706405
Harvey R. Kaslow, usilla L. Burns, Pertussis toxin and target eukaryotic cells: binding, entry, and activation. The FASEB Journal. ,vol. 6, pp. 2684- 2690 ,(1992) , 10.1096/FASEBJ.6.9.1612292
SERGE PRZEDBORSKI, MIQUEL VILA, The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson's disease. Annals of the New York Academy of Sciences. ,vol. 991, pp. 189- 198 ,(2006) , 10.1111/J.1749-6632.2003.TB07476.X
Chung Soo Lee, Eun Sook Han, Yoon Young Jang, Jeong Ho Han, Hyun Wook Ha, Doo Eung Kim, Protective effect of harmalol and harmaline on MPTP neurotoxicity in the mouse and dopamine-induced damage of brain mitochondria and PC12 cells. Journal of Neurochemistry. ,vol. 75, pp. 521- 531 ,(2002) , 10.1046/J.1471-4159.2000.0750521.X